Shivaani Kummar

Shivaani Kummar

Oregon Health & Science University - Portland / United States
Others
AD Scientific Index ID: 889054
person_outline Shivaani Kummar's MOST POPULAR ARTICLES
1-) Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and ChildrenA Drilon, TW Laetsch, S Kummar, SG DuBois, UN Lassen, GD Demetri, ...New England Journal of Medicine 378 (8), 731-739, 201818692018
2-) Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trialsDS Hong, SG DuBois, S Kummar, AF Farago, CM Albert, KS Rohrberg, ...The Lancet Oncology 21 (4), 531-540, 20204672020
3-) Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignanciesS Kummar, R Kinders, ME Gutierrez, L Rubinstein, RE Parchment, ...Journal of clinical oncology 27 (16), 2705, 20093662009
4-) Phase I study of single-agent AZD1775 (MK-1775), a Wee1 kinase inhibitor, in patients with refractory solid tumorsK Do, D Wilsker, J Ji, J Zlott, T Freshwater, RJ Kinders, J Collins, AP Chen, ...Journal of Clinical Oncology 33 (30), 3409-3415, 20153382015
5-) Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomasS Kummar, A Chen, J Ji, Y Zhang, JM Reid, M Ames, L Jia, M Weil, ...Cancer research 71 (17), 5626-5634, 20113052011